Study can't prove cause and effect, but saw dip in odds for people taking drugs such as Actos and Avandia WebMD News from HealthDay By Robert Preidt HealthDay Reporter TUESDAY, July 21, 2015 (HealthDay News) -- A class of diabetes meds that ... WebMD, 1 month ago
Common Diabetes Meds Tied to Lower Risk for Parkinson's - EverydayHealth.com, 1 month ago
1 images for "avandia"
A meta-analysis of data from more than 160,000 diabetics has offered some convincing data to support the theory that PPARγ activation by glitazones--either Avandia (GlaxoSmithKline'srosiglitazone) or pioglitazone--offers significant protection ...Fierce Biotech Research, 1 month ago
By: UK-based GW Pharmaceuticals has entered into a strategic alliance with Professor Mike Cawthorne and the Clore Laboratory, University of Buckingham, to research the use of cannabinoids-chemical compounds derived from marijuana-in the treatment of ...Diabetes Health Magazine, 14 hours ago
This comforting evidence that sitagliptin (Januvia) doesn't increase heart risk comes from a recent large randomized trial in the New England Journal of Medicine comparing the DPP-4 inhibitor with placebo in patients with a history of cardiovascular ...MedPage Today, 23 hours ago
By Kelly Close, Alexander Wolf, and Emily Regier Twitter Summary: Jardiance becomes 1st-ever #type2 #diabetes drug to reduce risk for heart attack + stroke Today, Lilly/BI announced first-ever news in diabetes: a major clinical trial on ...diaTribe, 3 days ago Jardiance Becomes First Ever Diabetes Drug to Improve Heart Health diaTribe, 1 week ago
Share this article: Different diabetes drugs may affect cardiovascular health in different ways. NEW ORLEANS — As new agents continue to revolutionize the treatment of diabetes, endocrinologists must weigh treatment options more ...Endocrinology Advisor, 2 weeks ago Consider Cardiovascular Effects of Diabetes Drugs Renal & Urology News, 2 weeks ago
You are here Insights by Stanford Business › Are Big Drug Companies Too Slow to Report Patient Deaths to the FDA? Accounting Health Care Public Sector Written Are Big Drug Companies Too Slow to Report Patient Deaths to the FDA? A new ...Stanford GSB, 1 month ago
The first author of a PLoS One paper that argued chronic traumatic encephalopathy might not be a widespread problem in contact sports belatedly acknowledged his financial ties to the NFL in a correction. ( Retraction Watch ) "I used to love ...MedPage Today, 1 month ago
Health plans and pharmacy benefits managers are expected to scrutinize the FDA approval to ensure that only those patients who truly need the drug get it.Drugmakers say discounts will cause the price to fall below the $14,600 annual wholesale price ...American Journal of Managed Care, 1 month ago
Actor Michael J. Fox funded the Michael J. Fox Foundation for Parkinson's Research after he was diagnosed with the disease in 1991. Photo: Rick Wilking/Reuters Two problematic diabetes drugs associated with worrying side effects may reduce the ...Times of Malta, 1 month ago Problematic diabetes drugs may protect against Parkinson's Yahoo! Finance UK and Ireland, 1 month ago *Problematic diabetes drugs may protect against Parkinson's Saudi Press Agency, 1 month ago
More from: , AlertNet...and 6 other sources
on your WebpageAdd Widget >Get your members hooked!